Defining the architecture of cerebrospinal fluid cellular communities in neuroinflammatory diseases
T. Roostaei, C. Diaconu, H. Touil, C. Harbison, Y. Zhang, S. Epstein, J. Tuddenham, K. Thakur, J. Bryois, H. Wiendl, G. Meyer zu Hörste, D. Malhotra, C. Riley, V. Menon, P. L. De Jager
This study uses scRNA-seq to define immune cell communities in CSF of MS and other neuroinflammatory diseases, identifying changes in cell types and potential therapeutic targets.
bioRxiv · Nov 1, 2021 · PreprintImmunology